Posts tagged PTN


Fixed: Canaccord Highlights Upcoming Catalysts For Palatin Technologies, Inc. (PTN) Bulls

John Newman continues to expect NDA in 2018 for bremelanotide, while pipeline moves forward.

Read more

This Analyst Sees 1035% Upside for Palatin Technologies, Inc. (PTN) Following New Deal with Fosun Pharma

PTN focusing on entering the EU market through partnerships, says analyst.

Read more

Canaccord Pounds The Table On Palatin Technologies, Inc. (PTN)

Canaccord analyst John Newman was out pounding the table on shares of Palatin Technologies, Inc.(NYSEMKT:PTN), reiterating …

Read more

3 Reasons to Buy Palatin Technologies, Inc. (PTN)

Palatin Technologies, Inc. (NYSEMKT:PTN) is circling up to be one of the market’s most undervalued …

Read more

Roth Capital Pounds The Table On Palatin Technologies, Inc. (PTN)

Roth Capital analyst Michael Higgins was out pounding the table on shares of Palatin Technologies, Inc. …

Read more

Monday’s Healthcare News: AMAG Pharmaceuticals, Inc. (AMAG), Galena Biopharma Inc (GALE), Ariad Pharmaceuticals, Inc. (ARIA)

Today’s healthcare sector offered a great deal of rumble and tumble with the following volatile …

Read more

Stock Update (NYSEMKT:PTN): Here’s Why Palatin Technologies, Inc. Shares Took a Hit Today

Palatin Technologies, Inc. (NYSEMKT:PTN) announced today that it intends to offer and sell, subject to …

Read more

Roth Capital Confident on Palatin Technologies, Inc. (PTN) Following F1Q17 Results

Yesterday, Palatin Technologies, Inc. (NYSEMKT:PTN) announced its fiscal first quarter results for 2017, with Roth …

Read more

Canaccord Bullish on Palatin Technologies, Inc. (PTN) Ahead of SSE Data and Partnership Update

Canaccord analyst John Newman speculates on Palatin Technologies, Inc. (NYSEMKT:PTN) ahead of clinical data and …

Read more

Roth Capital Cheers Palatin Technologies, Inc. (PTN) Clinical Success; Boosts Price Target

Palatin Technologies, Inc. (NYSEMKT:PTN) shares were on a close to 18% rise after market close …

Read more